RecruitingPhase 1Phase 2NCT06417411

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

A Prospective, Randomized Controlled Study to Evaluate the Effects of Daily Low Dose Aspirin in Pregnant Women With Sickle Cell Disease When Initiated at the First Trimester Versus the Second Trimester of the Gestational Period


Sponsor

Instituto Nacional de Investigacao em Saude, Angola

Enrollment

450 participants

Start Date

Mar 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gestational period.


Eligibility

Sex: FEMALEMin Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether low-dose aspirin can reduce the risk of preterm birth (being born too early) in pregnant women in Angola who have sickle cell disease — an inherited blood disorder that can cause serious pregnancy complications. **You may be eligible if...** - You are pregnant and 15 years old or older - You have sickle cell disease - You are attending specific hospitals or health facilities in Luanda, Angola - You are willing to attend regular appointments and consent to participate - You are in your first or second trimester (before 28 weeks of pregnancy) **You may NOT be eligible if...** - You are in your third trimester (after week 27 of pregnancy) - You have HIV infection - You have diabetes - You have chronic high blood pressure - You have significant liver disease - You have sickle cell-related kidney disease - You are carrying more than one baby - You have a known allergy to aspirin - You received a blood transfusion in the past 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAspirin 100mg

Daily use of low dose aspirin.


Locations(1)

Instituto Nacional de Investigação Em Saúde

Luanda, Angola

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06417411


Related Trials